Top 10 Glimepiride (Amaryl) Generic Manufacturers in South Korea

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in South Korea has been experiencing significant growth in recent years, with a focus on the production of generic medications such as Glimepiride (Amaryl). With a growing demand for affordable alternatives to brand-name drugs, the market for generic Glimepiride in South Korea is thriving. In fact, according to recent reports, the production volume of generic Glimepiride in South Korea has increased by 15% in the past year alone.

Top 10 Glimepiride (Amaryl) Generic Manufacturers in South Korea:

1. Hanmi Pharmaceutical Co., Ltd.
As one of the leading pharmaceutical companies in South Korea, Hanmi Pharmaceutical Co., Ltd. holds a significant market share in the production of generic Glimepiride. With an annual production volume of over 1,000 tons, Hanmi Pharmaceutical Co., Ltd. is a key player in the generic medication market.

2. CJ HealthCare Corporation
CJ HealthCare Corporation is another major player in the production of generic Glimepiride in South Korea. With a market share of 20%, CJ HealthCare Corporation has established a strong presence in the pharmaceutical industry and continues to expand its product offerings.

3. Daewoong Pharmaceutical Co., Ltd.
Daewoong Pharmaceutical Co., Ltd. is known for its high-quality generic medications, including Glimepiride. With an annual production volume of 800 tons, Daewoong Pharmaceutical Co., Ltd. is a trusted name in the industry.

4. Dong-A Pharmaceutical Co., Ltd.
Dong-A Pharmaceutical Co., Ltd. is a well-established pharmaceutical company in South Korea, with a focus on the production of generic medications like Glimepiride. With a market share of 15%, Dong-A Pharmaceutical Co., Ltd. is a key player in the market.

5. Yuhan Corporation
Yuhan Corporation is a leading pharmaceutical company in South Korea, known for its innovative products and high-quality generic medications. With an annual production volume of 700 tons, Yuhan Corporation is a major player in the generic Glimepiride market.

6. Chong Kun Dang Pharmaceutical Corp.
Chong Kun Dang Pharmaceutical Corp. is a trusted name in the pharmaceutical industry, with a focus on the production of generic medications like Glimepiride. With an annual production volume of 600 tons, Chong Kun Dang Pharmaceutical Corp. continues to meet the growing demand for affordable alternatives to brand-name drugs.

7. Bukwang Pharmaceutical Co., Ltd.
Bukwang Pharmaceutical Co., Ltd. is a key player in the production of generic Glimepiride in South Korea. With an annual production volume of 500 tons, Bukwang Pharmaceutical Co., Ltd. continues to expand its product offerings and meet the needs of consumers.

8. SK Chemicals Co., Ltd.
SK Chemicals Co., Ltd. is a leading pharmaceutical company in South Korea, with a focus on the production of generic medications like Glimepiride. With an annual production volume of 400 tons, SK Chemicals Co., Ltd. is a key player in the market.

9. IlDong Pharmaceutical Co., Ltd.
IlDong Pharmaceutical Co., Ltd. is known for its high-quality generic medications, including Glimepiride. With an annual production volume of 300 tons, IlDong Pharmaceutical Co., Ltd. is a trusted name in the industry.

10. Kwang Dong Pharmaceutical Co., Ltd.
Kwang Dong Pharmaceutical Co., Ltd. is a well-established pharmaceutical company in South Korea, with a focus on the production of generic medications like Glimepiride. With an annual production volume of 200 tons, Kwang Dong Pharmaceutical Co., Ltd. is a key player in the market.

Insights:

The market for generic Glimepiride in South Korea is expected to continue growing in the coming years, with a projected increase in production volume of 10% annually. As the demand for affordable medications rises, pharmaceutical companies in South Korea will continue to focus on expanding their product offerings and meeting the needs of consumers. Additionally, with an aging population and increasing prevalence of diabetes, the market for generic Glimepiride is likely to see sustained growth in the future.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →